Mary Feng, MD

Title(s)Professor, Radiation Oncology
SchoolSchool of Medicine
Address550 16th Street, #6403
San Francisco CA 94158
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford University, Stanford, CABS06/1997Biological Sciences
    University of Michigan, Ann Arbor, MI06/2007Radiation Oncology
    Washington University School of Medicine, Saint Louis, MOMD06/2002Medicine
    Collapse Awards and Honors
    Stanford University1996Howard Hughes Medical Institute Summer Research Fellowship
    Palo Alto, CA Chapter1998American Red Cross Volunteer of the Year
    Association of Residents in Radiation Oncology2020Educator of the Year

    Collapse Overview 
    Collapse Overview
    Dr. Mary Feng specializes in treating patients with cancers in the abdomen (gastrointestinal and hepatobiliary). Her approach is to make sure care is compassionate and coordinated. Her research uses advanced biology and technical advances to personalize and adapt radiation treatments for each patient to make treatment the most effective with the least amount of side effects. Her primary goals are 1) Improving the lives of patients with cancer through new combination treatments; 2) Adapting radiation treatments based on early changes in blood and imaging tests; and 3) Testing the use of advanced technologies in radiotherapy.

    Dr. Feng is Vice-Chair for Clinical Research in the Department of Radiation Oncology and the Medical Director of the Clinical Research Network Office in the Helen Diller Family Comprehensive Cancer Center, which brings clinical trials to patients closer to home at UCSF affiliates. She has also been the Clinical site director for the Mission Bay Clinic and Director of Quality Assurance and Safety for the Department of Radiation Oncology at UCSF. She also has served on numerous national and international cancer organization panels and groups, including the National Comprehensive Cancer Network Pancreatic Adenocarcinoma Panel, the American Society of Clinical Oncology Gastrointestinal Cancer Guideline Advisory Group, and the American Society for Radiation Oncology IHE-RO Clinical Advisory Subcommittee as co-chair.

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Operational Ontology for Oncology (O3): A Professional Society-Based, Multistakeholder, Consensus-Driven Informatics Standard Supporting Clinical and Research Use of Real-World Data From Patients Treated for Cancer. Int J Radiat Oncol Biol Phys. 2023 11 01; 117(3):533-550. Mayo CS, Feng MU, Brock KK, Kudner R, Balter P, Buchsbaum JC, Caissie A, Covington E, Daugherty EC, Dekker AL, Fuller CD, Hallstrom AL, Hong DS, Hong JC, Kamran SC, Katsoulakis E, Kildea J, Krauze AV, Kruse JJ, McNutt T, Mierzwa M, Moreno A, Palta JR, Popple R, Purdie TG, Richardson S, Sharp GC, Satomi S, Tarbox LR, Venkatesan AM, Witztum A, Woods KE, Yao Y, Farahani K, Aneja S, Gabriel PE, Hadjiiski L, Ruan D, Siewerdsen JH, Bratt S, Casagni M, Chen S, Christodouleas JC, DiDonato A, Hayman J, Kapoor R, Kravitz S, Sebastian S, Von Siebenthal M, Bosch W, Hurkmans C, Yom SS, Xiao Y. PMID: 37244628; PMCID: PMC10741247.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    2. Contrast-enhanced 4D-MRI for internal target volume generation in treatment planning for liver tumors. Radiother Oncol. 2022 08; 173:69-76. Thomas HR, Miao X, Ferguson D, Calvin C, Bhaskar Krishnamurthy U, Anwar M, Feng M, Scholey J. PMID: 35667575.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. A systematic review and meta-analysis of liver tumor position variability during SBRT using various motion management and IGRT strategies. Radiother Oncol. 2022 01; 166:195-202. Sharma M, Nano TF, Akkati M, Milano MT, Morin O, Feng M. PMID: 34843841.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    4. Outcomes after high-dose radiation in the management of neuroendocrine neoplasms. PLoS One. 2021; 16(6):e0252574. Chen KS, Lawhn-Heath C, Behr S, Juarez R, Whitman J, Paciorek A, Nakakura EK, Fidelman N, Feng MU, Bergsland EK, Anwar M. PMID: 34077464; PMCID: PMC8171937.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Use of advanced PET-volume metrics predicts risk of local recurrence and overall survival in anal cancer. PLoS One. 2021; 16(2):e0246535. Susko MS, Lazar AA, Wang CJ, Van Loon K, Feng M, Hope TA, Behr S, Anwar M. PMID: 33539412; PMCID: PMC7861457.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Factors Impacting Differential Outcomes in the Definitive Radiation Treatment of Anal Cancer Between HIV-Positive and HIV-Negative Patients. Oncologist. 2020 09; 25(9):772-779. Susko M, Wang CJ, Lazar AA, Kim S, Laffan A, Feng M, Ko A, Venook AP, Atreya CE, Van Loon K, Anwar M. PMID: 32390297; PMCID: PMC7485368.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    7. Big data analysis of associations between patient reported outcomes, observer reported toxicities, and overall quality of life in head and neck cancer patients treated with radiation therapy. Radiother Oncol. 2019 08; 137:167-174. Wilkie JR, Mierzwa ML, Yao J, Eisbruch A, Feng M, Weyburne G, Chen X, Holevinski L, Mayo CS. PMID: 31128357.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    8. Radiation Therapy in HCC: What Data Exist and What Data Do We Need to Incorporate into Guidelines? Semin Liver Dis. 2019 Feb; 39(1):43-52. Xu MJ, Feng M. PMID: 30536291.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    9. Radiotherapy for Hepatocellular Carcinoma. Semin Radiat Oncol. 2018 10; 28(4):277-287. Yu Y, Feng M. PMID: 30309638.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    10. Performance/outcomes data and physician process challenges for practical big data efforts in radiation oncology. Med Phys. 2018 Oct; 45(10):e811-e819. Matuszak MM, Fuller CD, Yock TI, Hess CB, McNutt T, Jolly S, Gabriel P, Mayo CS, Thor M, Caissie A, Rao A, Owen D, Smith W, Palta J, Kapoor R, Hayman J, Waddle M, Rosenstein B, Miller R, Choi S, Moreno A, Herman J, Feng M. PMID: 30229946; PMCID: PMC6679351.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    11. Comparing Modalities Using the National Cancer Database: Concerns With Rajyaguru et al. J Clin Oncol. 2018 08 20; 36(24):2557. Pollom EL, Feng M, Chang DT. PMID: 29945518.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare. J Med Imaging Radiat Oncol. 2018 Oct; 62(5):673-681. Parikh ND, Marshall VD, Green M, Lawrence TS, Razumilava N, Owen D, Singal AG, Feng M. PMID: 29877615.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    13. Interventions for improving management of chronic non-communicable diseases in Dikgale, a rural area in Limpopo Province, South Africa. BMC Health Serv Res. 2018 05 04; 18(1):331. Maimela E, Alberts M, Bastiaens H, Fraeyman J, Meulemans H, Wens J, Van Geertruyden JP. PMID: 29728147; PMCID: PMC5935929.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Quantification of liver function by linearization of a two-compartment model of gadoxetic acid uptake using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed. 2018 06; 31(6):e3913. Simeth J, Johansson A, Owen D, Cuneo K, Mierzwa M, Feng M, Lawrence TS, Cao Y. PMID: 29675932; PMCID: PMC5980790.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    15. Machine Learning in Radiation Oncology: Opportunities, Requirements, and Needs. Front Oncol. 2018; 8:110. Feng M, Valdes G, Dixit N, Solberg TD. PMID: 29719815; PMCID: PMC5913324.
      View in: PubMed   Mentions: 32  
    16. Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases. Am J Clin Oncol. 2018 04; 41(4):326-331. Shilkrut M, Sapir E, Hanasoge S, Schipper MJ, Normolle DP, Ben-Josef E, Ensminger W, Lawrence TS, Feng M. PMID: 26886946; PMCID: PMC4985493.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    17. Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial. JAMA Oncol. 2018 Jan 01; 4(1):40-47. Feng M, Suresh K, Schipper MJ, Bazzi L, Ben-Josef E, Matuszak MM, Parikh ND, Welling TH, Normolle D, Ten Haken RK, Lawrence TS. PMID: 28796864; PMCID: PMC5766368.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    18. Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases. Int J Radiat Oncol Biol Phys. 2018 03 15; 100(4):950-958. Jackson WC, Tao Y, Mendiratta-Lala M, Bazzi L, Wahl DR, Schipper MJ, Feng M, Cuneo KC, Lawrence TS, Owen D. PMID: 29485074; PMCID: PMC6142177.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    19. American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2018 03 15; 100(4):1057-1066. Mayo CS, Moran JM, Bosch W, Xiao Y, McNutt T, Popple R, Michalski J, Feng M, Marks LB, Fuller CD, Yorke E, Palta J, Gabriel PE, Molineu A, Matuszak MM, Covington E, Masi K, Richardson SL, Ritter T, Morgas T, Flampouri S, Santanam L, Moore JA, Purdie TG, Miller RC, Hurkmans C, Adams J, Jackie Wu QR, Fox CJ, Siochi RA, Brown NL, Verbakel W, Archambault Y, Chmura SJ, Dekker AL, Eagle DG, Fitzgerald TJ, Hong T, Kapoor R, Lansing B, Jolly S, Napolitano ME, Percy J, Rose MS, Siddiqui S, Schadt C, Simon WE, Straube WL, St James ST, Ulin K, Yom SS, Yock TI. PMID: 29485047; PMCID: PMC7437157.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    20. Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field Radiotherapy. Am J Clin Oncol. 2017 Oct; 40(5):517-522. Zhou J, Fang CX, Shen J, Schipper MJ, Zalupski MM, Minter RM, Simeone DM, Hart D, Eagle T, Kimmel GW, Vainshtein J, Lawrence TS, Feng M. PMID: 26165418.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    21. Using Indocyanine Green Extraction to Predict Liver Function After Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2018 01 01; 100(1):131-137. Suresh K, Owen D, Bazzi L, Jackson W, Ten Haken RK, Cuneo K, Feng M, Lawrence TS, Schipper MJ. PMID: 29128147; PMCID: PMC5736416.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    22. Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2018 01 01; 100(1):122-130. Sapir E, Tao Y, Schipper MJ, Bazzi L, Novelli PM, Devlin P, Owen D, Cuneo KC, Lawrence TS, Parikh ND, Feng M. PMID: 29066120; PMCID: PMC5818982.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    23. A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life. Pract Radiat Oncol. 2018 Jan - Feb; 8(1):40-47. Jackson WC, Dess RT, Litzenberg DW, Li P, Schipper M, Rosenthal SA, Chang GC, Horwitz EM, Price RA, Michalski JM, Gay HA, Wei JT, Feng M, Feng FY, Sandler HM, Wallace RE, Spratt DE, Hamstra DA. PMID: 29304991.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    24. Recent Time Trends and Predictors of Heart Dose From Breast Radiation Therapy in a Large Quality Consortium of Radiation Oncology Practices. Int J Radiat Oncol Biol Phys. 2017 12 01; 99(5):1154-1161. Pierce LJ, Feng M, Griffith KA, Jagsi R, Boike T, Dryden D, Gustafson GS, Benedetti L, Matuszak MM, Nurushev TS, Haywood J, Radawski JD, Speers C, Walker EM, Hayman JA, Moran JM, Michigan Radiation Oncology Quality Consortium. PMID: 28927756.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansPHPublic Health
    25. Dosimetric predictors for acute esophagitis during radiation therapy for lung cancer: Results of a large statewide observational study. Pract Radiat Oncol. 2018 May - Jun; 8(3):167-173. Paximadis P, Schipper M, Matuszak M, Feng M, Jolly S, Boike T, Grills I, Kestin L, Movsas B, Griffith K, Gustafson G, Moran J, Nurushev T, Radawski J, Pierce L, Hayman J, on behalf of, Michigan Radiation Oncology Quality Consortium. PMID: 28919249; PMCID: PMC6818411.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    26. Implementing Radiation Dose-Volume Liver Response in Biomechanical Deformable Image Registration. Int J Radiat Oncol Biol Phys. 2017 11 15; 99(4):1004-1012. Polan DF, Feng M, Lawrence TS, Ten Haken RK, Brock KK. PMID: 28864401; PMCID: PMC5654673.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    27. Synthetic CT for MRI-based liver stereotactic body radiotherapy treatment planning. Phys Med Biol. 2017 04 21; 62(8):2922-2934. Bredfeldt JS, Liu L, Feng M, Cao Y, Balter JM. PMID: 28306547; PMCID: PMC5495654.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    28. Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study. Radiology. 2017 05; 283(2):460-468. Pollom EL, Lee K, Durkee BY, Grade M, Mokhtari DA, Wahl DR, Feng M, Kothary N, Koong AC, Owens DK, Goldhaber-Fiebert J, Chang DT. PMID: 28045603; PMCID: PMC5410949.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    29. Development of a model web-based system to support a statewide quality consortium in radiation oncology. Pract Radiat Oncol. 2017 May - Jun; 7(3):e205-e213. Moran JM, Feng M, Benedetti LA, Marsh R, Griffith KA, Matuszak MM, Hess M, McMullen M, Fisher JH, Nurushev T, Grubb M, Gardner S, Nielsen D, Jagsi R, Hayman JA, Pierce LJ, Michigan Radiation Oncology Quality Consortium. PMID: 28196607.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    30. The big data effort in radiation oncology: Data mining or data farming? Adv Radiat Oncol. 2016 Oct-Dec; 1(4):260-271. Mayo CS, Kessler ML, Eisbruch A, Weyburne G, Feng M, Hayman JA, Jolly S, El Naqa I, Moran JM, Matuszak MM, Anderson CJ, Holevinski LP, McShan DL, Merkel SM, Machnak SL, Lawrence TS, Ten Haken RK. PMID: 28740896; PMCID: PMC5514231.
      View in: PubMed   Mentions: 28  
    31. Optimizing global liver function in radiation therapy treatment planning. Phys Med Biol. 2016 09 07; 61(17):6465-84. Wu VW, Epelman MA, Wang H, Edwin Romeijn H, Feng M, Cao Y, Ten Haken RK, Matuszak MM. PMID: 27518786; PMCID: PMC5237377.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    32. Reply to Yang et al and De Bari et al. J Clin Oncol. 2016 08 10; 34(23):2799. Wahl DR, Tao Y, Schipper M, Lawrence TS, Feng M. PMID: 27325853; PMCID: PMC5019762.
      View in: PubMed   Mentions:    Fields:    
    33. Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 10 01; 96(2):354-361. Sapir E, Tao Y, Feng F, Samuels S, El Naqa I, Murdoch-Kinch CA, Feng M, Schipper M, Eisbruch A. PMID: 27473816.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    34. Failure mode and effects analysis in a dual-product microsphere brachytherapy environment. Pract Radiat Oncol. 2016 Nov - Dec; 6(6):e299-e306. Younge KC, Lee C, Moran JM, Feng M, Novelli P, Prisciandaro JI. PMID: 27155761.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    35. Enhancing safety and quality through preplanning peer review for patients undergoing stereotactic body radiation therapy. Pract Radiat Oncol. 2016 Mar-Apr; 6(2):e39-46. Matuszak MM, Hadley SW, Feng M, Hayman JA, Brock KK, Burger P, Owen D, Suresh K, Schipper M, Lawrence TS, Moran JM. PMID: 26746815.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    36. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma. J Clin Oncol. 2016 Feb 10; 34(5):452-9. Wahl DR, Stenmark MH, Tao Y, Pollom EL, Caoili EM, Lawrence TS, Schipper MJ, Feng M. PMID: 26628466; PMCID: PMC4872011.
      View in: PubMed   Mentions: 210     Fields:    Translation:Humans
    37. Local and Global Function Model of the Liver. Int J Radiat Oncol Biol Phys. 2016 Jan 01; 94(1):181-188. Wang H, Feng M, Jackson A, Ten Haken RK, Lawrence TS, Cao Y. PMID: 26700712; PMCID: PMC4692182.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    38. Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort. JAMA Oncol. 2015 Oct; 1(7):918-30. Jagsi R, Griffith KA, Boike TP, Walker E, Nurushev T, Grills IS, Moran JM, Feng M, Hayman J, Pierce LJ. PMID: 26247417.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansPHPublic Health
    39. Assessing the Dosimetric Accuracy of Magnetic Resonance-Generated Synthetic CT Images for Focal Brain VMAT Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015 Dec 01; 93(5):1154-61. Paradis E, Cao Y, Lawrence TS, Tsien C, Feng M, Vineberg K, Balter JM. PMID: 26581151; PMCID: PMC4654706.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    40. Stereotactic Body Radiation Therapy for Liver Cancer: Effective Therapy With Minimal Impact on Quality of Life. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):26-8. Feng M, Brunner TB, Ben-Josef E. PMID: 26279021.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    41. A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma. Eur J Cancer. 2015 Sep; 51(13):1794-802. Davis EJ, Chugh R, Zhao L, Lucas DR, Biermann JS, Zalupski MM, Feng M, Wong SL, Jacobson J, Zyczynski L, Reinke D, Metko G, Baker LH, Schuetze SM. PMID: 26066736.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    42. Quantitative characterizations of ultrashort echo (UTE) images for supporting air-bone separation in the head. Phys Med Biol. 2015 Apr 07; 60(7):2869-80. Hsu SH, Cao Y, Lawrence TS, Tsien C, Feng M, Grodzki DM, Balter JM. PMID: 25776205; PMCID: PMC4405190.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    43. Wide Variation in the Diffusion of a New Technology: Practice-Based Trends in Intensity-Modulated Radiation Therapy (IMRT) Use in the State of Michigan, With Implications for IMRT Use Nationally. J Oncol Pract. 2015 May; 11(3):e373-9. Shumway DA, Griffith KA, Pierce LJ, Feng M, Moran JM, Stenmark MH, Jagsi R, Hayman JA. PMID: 25736383.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    44. The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework. J Multidiscip Healthc. 2015; 8:109-15. Siegel GW, Biermann JS, Chugh R, Jacobson JA, Lucas D, Feng M, Chang AC, Smith SR, Wong SL, Hasen J. PMID: 25733913; PMCID: PMC4340372.
      View in: PubMed   Mentions: 18  
    45. Choosing wisely? Patterns and correlates of the use of hypofractionated whole-breast radiation therapy in the state of Michigan. Int J Radiat Oncol Biol Phys. 2014 Dec 01; 90(5):1010-6. Jagsi R, Griffith KA, Heimburger D, Walker EM, Grills IS, Boike T, Feng M, Moran JM, Hayman J, Pierce LJ, Michigan Radiation Oncology Quality Consortium. PMID: 25539366.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    46. A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer. Transl Oncol. 2014 Oct; 7(5):644-9. Cuneo KC, Chenevert TL, Ben-Josef E, Feng MU, Greenson JK, Hussain HK, Simeone DM, Schipper MJ, Anderson MA, Zalupski MM, Al-Hawary M, Galban CJ, Rehemtulla A, Feng FY, Lawrence TS, Ross BD. PMID: 25389460; PMCID: PMC4225651.
      View in: PubMed   Mentions: 28  
    47. Getting to the heart of the matter. J Natl Cancer Inst. 2014 Aug; 106(8). Feng M, Pierce LJ. PMID: 25128696.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    48. Renal remodeling after abdominal radiation therapy: parenchymal and functional changes. AJR Am J Roentgenol. 2014 Aug; 203(2):W192-8. Tran LK, Maturen KE, Feng MU, Wizauer EJ, Watcharotone K, Parker RA, Ellis JH. PMID: 25055293.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    49. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2014 Aug; 12(8):1083-93. Tempero MA, Malafa MP, Behrman SW, Benson AB, Casper ES, Chiorean EG, Chung V, Cohen SJ, Czito B, Engebretson A, Feng M, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Lowy AM, Ma WW, Merchant NB, Mulvihill SJ, Muscarella P, Nakakura EK, Obando J, Pitman MB, Reddy S, Sasson AR, Thayer SP, Weekes CD, Wolff RA, Wolpin BM, Burns JL, Freedman-Cass DA. PMID: 25099441.
      View in: PubMed   Mentions: 127     Fields:    Translation:Humans
    50. Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelines. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):804-13. Hong TS, Bosch WR, Krishnan S, Kim TK, Mamon HJ, Shyn P, Ben-Josef E, Seong J, Haddock MG, Cheng JC, Feng MU, Stephans KL, Roberge D, Crane C, Dawson LA. PMID: 24969794; PMCID: PMC4285340.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    51. Low dose rate radiosensitization of hepatocellular carcinoma in vitro and in patients. Transl Oncol. 2014 Aug; 7(4):472-8. Cuneo KC, Davis MA, Feng MU, Novelli PM, Ensminger WD, Lawrence TS. PMID: 24956939; PMCID: PMC4202782.
      View in: PubMed   Mentions: 3  
    52. Estimating functional liver reserve following hepatic irradiation: adaptive normal tissue response models. Radiother Oncol. 2014 Jun; 111(3):418-23. Stenmark MH, Cao Y, Wang H, Jackson A, Ben-Josef E, Ten Haken RK, Lawrence TS, Feng M. PMID: 24813090; PMCID: PMC4119482.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    53. Arterial perfusion imaging-defined subvolume of intrahepatic cancer. Int J Radiat Oncol Biol Phys. 2014 May 01; 89(1):167-74. Wang H, Farjam R, Feng M, Hussain H, Ten Haken RK, Lawrence TS, Cao Y. PMID: 24613814; PMCID: PMC3988211.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    54. Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma. Liver Transpl. 2014 Jan; 20(1):81-8. Welling TH, Feng M, Wan S, Hwang SY, Volk ML, Lawrence TS, Zalupski MM, Sonnenday CJ. PMID: 24115315; PMCID: PMC4185427.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    55. Investigation of a method for generating synthetic CT models from MRI scans of the head and neck for radiation therapy. Phys Med Biol. 2013 Dec 07; 58(23):8419-35. Hsu SH, Cao Y, Huang K, Feng M, Balter JM. PMID: 24217183; PMCID: PMC3886820.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    56. Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2013 Nov 15; 87(4):676-82. Hunter KU, Fernandes LL, Vineberg KA, McShan D, Antonuk AE, Cornwall C, Feng M, Schipper MJ, Balter JM, Eisbruch A. PMID: 24035328; PMCID: PMC3805710.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    57. Stereotactic body radiation therapy for primary and metastatic liver tumors. Transl Oncol. 2013 Aug; 6(4):442-6. Liu E, Stenmark MH, Schipper MJ, Balter JM, Kessler ML, Caoili EM, Lee OE, Ben-Josef E, Lawrence TS, Feng M. PMID: 23908687; PMCID: PMC3730019.
      View in: PubMed   Mentions: 21  
    58. Use of plan quality degradation to evaluate tradeoffs in delivery efficiency and clinical plan metrics arising from IMRT optimizer and sequencer compromises. Med Phys. 2013 Jul; 40(7):071708. Wilkie JR, Matuszak MM, Feng M, Moran JM, Fraass BA. PMID: 23822412; PMCID: PMC3695972.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    59. Predictive models for regional hepatic function based on 99mTc-IDA SPECT and local radiation dose for physiologic adaptive radiation therapy. Int J Radiat Oncol Biol Phys. 2013 Aug 01; 86(5):1000-6. Wang H, Feng M, Frey KA, Ten Haken RK, Lawrence TS, Cao Y. PMID: 23688813; PMCID: PMC3710542.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    60. Renal remodeling in the first 24 months after abdominal radiotherapy. Pract Radiat Oncol. 2013 Apr-Jun; 3(2 Suppl 1):S6. Tran LK, Maturen KE, Feng MU, Wizauer E, Watcharotone K, Ellis JH. PMID: 24674564.
      View in: PubMed   Mentions: 1     Fields:    
    61. Hepatic Function Model Based Upon HIDA SPECT and Dose for Physiological Adaptive RT. Pract Radiat Oncol. 2013 Apr-Jun; 3(2 Suppl 1):S2. Wang H, Feng M, Frey K, Balter J, Haken RT, Lawrence T, Cao Y. PMID: 24674506.
      View in: PubMed   Mentions: 1     Fields:    
    62. Imaging effects of radiation therapy in the abdomen and pelvis: evaluating "innocent bystander" tissues. Radiographics. 2013 Mar-Apr; 33(2):599-619. Maturen KE, Feng MU, Wasnik AP, Azar SF, Appelman HD, Francis IR, Platt JF. PMID: 23479716.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansPHPublic Health
    63. Is there a dose-response relationship for heart disease with low-dose radiation therapy? Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):959-64. Chung E, Corbett JR, Moran JM, Griffith KA, Marsh RB, Feng M, Jagsi R, Kessler ML, Ficaro EC, Pierce LJ. PMID: 23021709; PMCID: PMC5175458.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    64. Sensitivity analysis for lexicographic ordering in radiation therapy treatment planning. Med Phys. 2012 Jun; 39(6):3445-55. Long T, Matuszak M, Feng M, Fraass BA, Ten Haken RK, Romeijn HE. PMID: 22755724; PMCID: PMC3371080.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    65. Normal tissue anatomy for oropharyngeal cancer: contouring variability and its impact on optimization. Int J Radiat Oncol Biol Phys. 2012 Oct 01; 84(2):e245-9. Feng M, Demiroz C, Vineberg KA, Eisbruch A, Balter JM. PMID: 22583602; PMCID: PMC3432166.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    66. Dosimetric analysis of radiation-induced gastric bleeding. Int J Radiat Oncol Biol Phys. 2012 Sep 01; 84(1):e1-6. Feng M, Normolle D, Pan CC, Dawson LA, Amarnath S, Ensminger WD, Lawrence TS, Ten Haken RK. PMID: 22541965; PMCID: PMC3423508.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    67. Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging. Int J Radiat Oncol Biol Phys. 2013 Jan 01; 85(1):258-63. Cao Y, Wang H, Johnson TD, Pan C, Hussain H, Balter JM, Normolle D, Ben-Josef E, Ten Haken RK, Lawrence TS, Feng M. PMID: 22520476; PMCID: PMC3629546.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    68. Risk factors for local recurrence and metastasis in soft tissue sarcomas of the extremity. Am J Clin Oncol. 2012 Apr; 35(2):151-7. Sabolch A, Feng M, Griffith K, Rzasa C, Gadzala L, Feng F, Biermann JS, Chugh R, Ray M, Ben-Josef E. PMID: 21336091.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    69. A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):1441-7. Feng M, Smith DE, Normolle DP, Knol JA, Pan CC, Ben-Josef E, Lu Z, Feng MR, Chen J, Ensminger W, Lawrence TS. PMID: 22440042; PMCID: PMC3383372.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    70. Potential use of ultrasound speckle tracking for motion management during radiotherapy: preliminary report. J Ultrasound Med. 2012 Mar; 31(3):469-81. Rubin JM, Feng M, Hadley SW, Fowlkes JB, Hamilton JD. PMID: 22368138.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    71. The cortisol response to hypobaric hypoxia at rest and post-exercise. Horm Metab Res. 2012 Apr; 44(4):302-5. Woods DR, Davison A, Stacey M, Smith C, Hooper T, Neely D, Turner S, Peaston R, Mellor A. PMID: 22368038.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    72. Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer. Med Dosim. 2012; 37(3):240-4. Stenmark MH, Vineberg K, Ten Haken RK, Hamstra DA, Feng M. PMID: 22189029.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    73. Dose--effect relationships for femoral fractures after multimodality limb-sparing therapy of soft-tissue sarcomas of the proximal lower extremity. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):1257-63. Pak D, Vineberg KA, Griffith KA, Sabolch A, Chugh R, Ben-Josef E, Biermann JS, Feng M. PMID: 22099042.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    74. Radiation therapy for hepatocellular carcinoma. Semin Radiat Oncol. 2011 Oct; 21(4):271-7. Feng M, Ben-Josef E. PMID: 21939856.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    75. Adjuvant and definitive radiotherapy for adrenocortical carcinoma. Int J Radiat Oncol Biol Phys. 2011 Aug 01; 80(5):1477-84. Sabolch A, Feng M, Griffith K, Hammer G, Doherty G, Ben-Josef E. PMID: 20675074.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    76. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol. 2010 Jun 01; 28(16):2732-8. Feng FY, Kim HM, Lyden TH, Haxer MJ, Worden FP, Feng M, Moyer JS, Prince ME, Carey TE, Wolf GT, Bradford CR, Chepeha DB, Eisbruch A. PMID: 20421546; PMCID: PMC2881852.
      View in: PubMed   Mentions: 116     Fields:    Translation:Humans
    77. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2011 Jan 01; 79(1):10-8. Feng M, Moran JM, Koelling T, Chughtai A, Chan JL, Freedman L, Hayman JA, Jagsi R, Jolly S, Larouere J, Soriano J, Marsh R, Pierce LJ. PMID: 20421148; PMCID: PMC2937165.
      View in: PubMed   Mentions: 262     Fields:    Translation:HumansPHPublic Health
    78. Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy. Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):369-78. McLaughlin PW, Evans C, Feng M, Narayana V. PMID: 19515511.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    79. Characterization of pancreatic tumor motion using cine MRI: surrogates for tumor position should be used with caution. Int J Radiat Oncol Biol Phys. 2009 Jul 01; 74(3):884-91. Feng M, Balter JM, Normolle D, Adusumilli S, Cao Y, Chenevert TL, Ben-Josef E. PMID: 19395190; PMCID: PMC2691867.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    80. Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys. 2009 Mar 15; 73(4):1228-34. Feng M, Kong FM, Gross M, Fernando S, Hayman JA, Ten Haken RK. PMID: 19251094; PMCID: PMC3381895.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansPHPublic Health
    81. Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma. Int J Radiat Oncol Biol Phys. 2007 Sep 01; 69(1):103-10. Feng M, Murphy J, Griffith KA, Baker LH, Sondak VK, Lucas DR, McGinn CJ, Ray ME. PMID: 17560050.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    82. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1289-98. Feng FY, Kim HM, Lyden TH, Haxer MJ, Feng M, Worden FP, Chepeha DB, Eisbruch A. PMID: 17560051.
      View in: PubMed   Mentions: 145     Fields:    Translation:HumansCTClinical Trials
    83. Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1417-23. Feng M, Hanlon AL, Pisansky TM, Kuban D, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Pollack A, Kestin LL, Valicenti RK, DeWeese TL, Sandler HM. PMID: 17418972.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    84. Future issues in highly conformal radiotherapy for head and neck cancer. J Clin Oncol. 2007 Mar 10; 25(8):1009-13. Feng M, Eisbruch A. PMID: 17350951.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    85. Adjuvant therapy for pancreatic cancer: the glass is half empty. Nat Clin Pract Oncol. 2007 Mar; 4(3):148-9. Feng M, Ben-Josef E. PMID: 17245345.
      View in: PubMed   Mentions:    Fields:    
    86. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys. 2005 Nov 01; 63(3):725-31. Jabbari S, Kim HM, Feng M, Lin A, Tsien C, Elshaikh M, Terrel JE, Murdoch-Kinch C, Eisbruch A. PMID: 16199308.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    87. Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer. Radiother Oncol. 2005 Oct; 77(1):32-8. Feng M, Jabbari S, Lin A, Bradford CR, Chepeha DB, Teknos TN, Worden FP, Tsien C, Schipper MJ, Wolf GT, Dawson LA, Eisbruch A. PMID: 16154219.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    Mary's Networks
    Concepts (317)
    Derived automatically from this person's publications.
    Co-Authors (24)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department